Stay updated on IMU-131 HER-Vaxx in HER2+ Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the IMU-131 HER-Vaxx in HER2+ Gastric Cancer Clinical Trial page.

Latest updates to the IMU-131 HER-Vaxx in HER2+ Gastric Cancer Clinical Trial page
- Check4 days agoChange DetectedA new revision tag v3.5.5 has been added to the record history. The previous revision v3.5.4 has been removed.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedA new revision entry, v3.5.4, has been added to the study's history to replace the previous v3.5.3, indicating an administrative update to the record. This reflects an update to the documentation rather than any changes to the study content.SummaryDifference0.1%

- Check47 days agoChange DetectedA minor update to the website’s revision/version label was made, changing the displayed revision from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check54 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check83 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3 in the Record History.SummaryDifference0.1%

- Check90 days agoChange DetectedAdded revision v3.4.3 and removed revision v3.4.2 from the page history.SummaryDifference0.1%

Stay in the know with updates to IMU-131 HER-Vaxx in HER2+ Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMU-131 HER-Vaxx in HER2+ Gastric Cancer Clinical Trial page.